Clinical trial
Evaluation of Cannabidiol for Reduction of Brain Neuroinflammation
NCT05066308 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Cannabidiol for Reduction of Brain Neuroinflammation
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- January 4, 2022
- Completion date
- December 15, 2026
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
back pain, depressive symptoms